In human medicine, genetic mapping of tumors that have already metastasized has added years to the lives of cancer patients who otherwise would have been near death. By understanding the exact nature of the genetic mutation that caused the cancer, scientists have been able to develop drugs that target malignant tumors with incredible precision, effectively pushing back the advance of life-threatening disease. Now, veterinary researchers have begun the process of pinning down the genomes of tumors in dogs.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to Tufts Your Dog
Get the next year of Tufts Your Dog for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 44%. It's like getting 5 months FREE!
